Breelyn A. Wilky, MD
Dr. Breelyn A. Wilky, MD is a sarcoma medical oncologist and clinical trialist with research interests in immunotherapy, targeted therapy and precision medicine, and early phase drug development. She is Associate Professor and Director of the Sarcoma Program at the University of Colorado School of Medicine, and is a member of the Phase One and Experimental Molecular Therapeutics (POEMS) research program. As the Deputy Associate Director of Clinical Research for the University of Colorado Cancer Center, she leads the investigator-initiated clinical trials committee to help advance novel research to the clinic. Her laboratory studies the tumor and immune microenvironment of sarcomas, to identify new drugs that boost the immune system for future clinical trials in sarcoma.
Dr. Wilky received her undergraduate degree in Biology and Music from Bates College in Lewiston, Maine, and attended medical school at the University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School in Piscataway, New Jersey (now Rutgers Medical School.) She received her MD with Distinction in Research. She then completed the Osler internship and residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland, and stayed on to complete her fellowship in Medical Oncology. Her honors and awards include election to the Alpha Omega Alpha Honor Medical Society, an ASCO/Conquer Cancer Foundation Young Investigator Award in 2012, the 2017 Outstanding Clinical Researcher of the Year at Sylvester Comprehensive Cancer Center at the University of Miami, and is the recipient of an American Cancer Society Mentored Research Scholar Grant to further her research in understanding the role of the immune system in fighting sarcomas.